Cleared Traditional

K151152 - ImplantMax Software

K151152 is an FDA 510(k) clearance for ImplantMax Software, manufactured by Saturn Imaging, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 257-day FDA review.

K151152 · Saturn Imaging, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
257d
Days
Class 2
Risk

K151152 is an FDA 510(k) clearance for the ImplantMax Software. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Saturn Imaging, Inc. (New Taipei City, TW). The FDA issued a Cleared decision on January 12, 2016 after a review of 257 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Saturn Imaging, Inc. devices

FDA 510(k) Submission Details - K151152

510(k) Number K151152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2015
Decision Date January 12, 2016
Days to Decision 257 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 107d · This submission: 257d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1236
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K151152.
CARESTREAM Vue PACS
K153103 · Carestream Health, Inc. · Feb 2016
Synapse PACS
K160108 · Fujifilm Medical Systems U.S.A, Inc. · Feb 2016
Stereo 3D option for Vision Applications
K152352 · GE Medical Systems SCS · Jan 2016
Ez3D Plus
K152746 · Ewoosoft Co., Ltd. · Jan 2016
Econsole1
K152172 · DRTECH Corporation · Dec 2015
UroNav (Version 2.0)
K153073 · Invivo Corporation · Nov 2015